Frontlight ResearchEarly access
Trial site
El Faro Health and Therapeutics
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Mild cognitive impairment2 trials
- Phase
- Phase 34 trials
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Hoffmann-La Roche2 trials
Running trials
Active, not recruiting
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Mild cognitive impairment1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026